| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $27.9M | — | -6.3% |
| Cost of Revenue | $15.8M | — | -15.6% |
| Gross Profit | $12.1M | — | +9.3% |
| R&D Expense | $5.6M | — | +1.9% |
| SG&A Expense | $10.1M | — | +21.9% |
| Operating Income | -$16.9M | — | -3.2% |
| Interest Expense | $3.4M | — | -5.4% |
| Pre-tax Income | -$18.8M | — | +26.9% |
| Income Tax | $217K | — | +88.7% |
| Net Income | -$19.0M | — | +26.4% |
| EPS (Basic) | -$1.03 | — | +71.9% |
| EPS (Diluted) | -$1.03 | — | +71.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $30.6M | -12.7% | -59.7% |
| Short-term Investments | $126.1M | -5.8% | +11.6% |
| Accounts Receivable | $25.3M | -10.6% | -31.4% |
| Inventory | $49.6M | +4.3% | -11.0% |
| Current Assets | $236.7M | -5.6% | -17.4% |
| Total Assets | $249.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$12.8M | — | +50.0% |
| Capital Expenditures | $65K | — | -47.2% |
| Investing Cash Flow | $7.9M | — | +110.1% |
| Financing Cash Flow | $501K | — | -99.1% |
| Free Cash Flow | -$12.9M | — | +49.9% |
| -17.2% |
| Current Liabilities | $37.6M | -0.1% | +9.9% |
| Long-term Debt | $96.9M | +0.7% | +3.0% |
| Total Liabilities | $137.8M | +0.2% | +4.9% |
| Stockholders' Equity | $111.7M | -12.0% | -34.3% |